Skip to main content

Table 2 Key characteristics of individuals with suboptimal or no mood stabilizer treatment

From: Is cognitive behaviour therapy applicable to individuals diagnosed with bipolar depression or suboptimal mood stabilizer treatment: a secondary analysis of a large pragmatic effectiveness trial

 

TAU (n = 20)

CBT (n = 19)

Mean age (SD)

43.1 (10.97)

41. 21 (11.3)

Female

14 (70%)

14 (74%)

Current comorbid mental disorder

6 (30%)

10 (53%)

Current substance misuse

2 (10%)

1 (5%)

Median HRSD score (IQR)

6 (3, 9)

7 (3, 10)

Median BRMS score (IQR)

2 (0, 3)

2, (1, 3)

Median number of episodes:

Major depression (IQR)

3.8 (1–9)

4 (1–10)

Mania/hypomania/mixed (IQR)

3 (2–6)

2.9 (2–6)

Current medication

 None

2 (10%)

1 (5%)

 Benzodiazepine monotherapy

0

1 (5%)

 Anti-depressant monotherapy

6 (30%)

5 (26%)

Other medication

2 (10%)

4 (21%)

Current adherence level < 50%

11 (55%)

11 (58%)

  1. Adherence level measured using the tablet routines questionnaire
  2. SD standard deviation, IQR inter-quartile range